# Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

> **NCT05376111** · PHASE2 · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 28 (estimated)

## Conditions studied

- T-cell Acute Lymphoblastic Leukemia
- Recruiting

## Interventions

- **DRUG:** Venetoclax, Azacitidine

## Key facts

- **NCT ID:** NCT05376111
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376111, "Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05376111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*